Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Contact

Faster, Cleaner, Better.

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
company
analysts
- Earnings Estimates
- Analyst Ratings
financials

Hookipa Pharma Inc (HOOK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

News & Headlines for [[ item.sessionDateDisplayLong ]]

Notes

Alerts

Watch

Help

HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics GlobeNewswire - Thu Mar 26, 6:00AM CDT

NEW YORK and VIENNA, March 26, 2026 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”, the “Company”) today announced the completion of the sale of its immuno-oncology related assets,...

HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics GlobeNewswire - Tue Feb 3, 7:30AM CST

NEW YORK and VIENNA, Austria, Feb. 03, 2026 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”, the “Company”) today announced the sale of its immuno-oncology related assets, consisting...

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead GlobeNewswire - Fri Oct 31, 2025

NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program...

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock GlobeNewswire - Fri Jul 18, 2025

NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for...

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV GlobeNewswire - Thu Jan 30, 2025

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements GlobeNewswire - Tue Jan 7, 2025

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates GlobeNewswire - Thu Nov 14, 2024

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker GlobeNewswire - Mon Nov 11, 2024

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 GlobeNewswire - Thu Oct 31, 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer GlobeNewswire - Wed Oct 30, 2024